Showing 341 - 360 results of 2,482 for search '"hepatitis"', query time: 0.07s Refine Results
  1. 341
  2. 342

    Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases by Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, Po-Chin Liang, Ann-Lii Cheng, Zhong-Zhe Lin

    Published 2013-01-01
    “…On account of the dual vascular supply system and the fact that most metastatic liver tumors are supplied by the hepatic artery, hepatic artery infusion chemotherapy (HAIC) is an appealing method for the treatment of liver metastases. …”
    Get full text
    Article
  3. 343
  4. 344
  5. 345
  6. 346

    CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian Guidelines for the Treatment of Hepatitis C Infection in HIV-hepatitis C Coinfected Adults by Mark Hull, Stephen Shafran, Alice Tseng, Pierre Giguère, Marina B Klein, Curtis Cooper

    Published 2014-01-01
    “…BACKGROUND: Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV and is responsible for a heavy burden of morbidity and mortality. …”
    Get full text
    Article
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356

    Herpes Simplex Virus-2 Hepatitis: A Case Report and Review of the Literature by Amna Ahmed, Alejandro Granillo, Ethan Burns, Kerri Glassner, Nishath Naseem, Christopher Force, Suzanne M. Crumley, Ashley Drews

    Published 2020-01-01
    “…Herpes simplex virus (HSV) is a rare cause of hepatitis in pregnancy and the chronically immunosuppressed, with a high propensity to progress to acute liver failure (ALF) and death. …”
    Get full text
    Article
  17. 357

    Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis by Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, Chuan-Yong Guo

    Published 2013-01-01
    “…Many studies have found that the antibiotic rifaximin is effective for the treatment of hepatic encephalopathy. However, there is no uniform view on the efficacy and safety of rifaximin. …”
    Get full text
    Article
  18. 358

    Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling by Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang

    Published 2025-01-01
    “…The liver organoids also serve as ideal platforms for studying liver diseases such as hepatitis, liver fibrosis, viral liver diseases, and monogenic diseases. …”
    Get full text
    Article
  19. 359
  20. 360